Intravesical cretostimogene grenadenorepvec oncolytic immunotherapy in high-risk, BCG-unresponsive, non-muscle-invasive bladder cancer with carcinoma in situ (BOND-003 Cohort C): a single-arm, phase 3 trial.

cretostimogene grenadenorepvec (CG0070) - CG Oncology

http://www.ncbi.nlm.nih.gov/pubmed/42508433

Ben Tran; Edward M Uchio; Gary D Steinberg; Hiroshi Kitamura; James M Burke; Jong-Kil Nam; Mark D Tyson; Neal D Shore; Roger Li; Seung Il Jung; Shreyas S Joshi; Trinity J Bivalacqua

Jul 28, 2026